Hoersholm, Denmark

Lars-Ole Gerlach

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: 7Tm Pharma A/s. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars-Ole Gerlach. Retrieved from https://idiyas.com/inventor/lars-ole-gerlach-a4qj2r7o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars-Ole Gerlach: Innovator in Therapeutic Interventions

Introduction

Lars-Ole Gerlach is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of therapeutic interventions, particularly through his innovative work on selective receptor agonists.

Latest Patents

Gerlach holds a patent for "Y4 selective receptor agonists for therapeutic interventions." This patent includes a Y4 receptor agonist peptide selected from a specific group of compounds. These compounds are selective agonists of the Y4 receptor relative to the Y1 and Y2 receptors. They are particularly useful in treating obesity, overweight conditions, and diarrhoea, as well as intestinal hypersecretion.

Career Highlights

Lars-Ole Gerlach is associated with 7tm Pharma A/S, where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues that address significant health issues.

Collaborations

Gerlach has collaborated with notable colleagues such as Thue Schwartz and Paul Brian Little. Their combined expertise has contributed to the success of their projects and innovations.

Conclusion

Lars-Ole Gerlach's work exemplifies the impact of innovative thinking in the field of therapeutic interventions. His contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…